Success Metrics

Clinical Success Rate
88.5%

Based on 23 completed trials

Completion Rate
88%(23/26)
Active Trials
20(31%)
Results Posted
17%(4 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_1
2
3%
Ph phase_3
1
2%
Ph not_applicable
22
34%
Ph phase_4
2
3%
Ph phase_2
2
3%

Phase Distribution

2

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
2(6.9%)
Phase 2Efficacy & side effects
2(6.9%)
Phase 3Large-scale testing
1(3.4%)
Phase 4Post-market surveillance
2(6.9%)
N/ANon-phased studies
22(75.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.7%

23 of 30 finished

Non-Completion Rate

23.3%

7 ended early

Currently Active

20

trials recruiting

Total Trials

65

all time

Status Distribution
Active(24)
Completed(23)
Terminated(7)
Other(11)

Detailed Status

Completed23
Recruiting16
unknown11
Active, not recruiting4
Withdrawn4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
65
Active
20
Success Rate
88.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (6.9%)
Phase 22 (6.9%)
Phase 31 (3.4%)
Phase 42 (6.9%)
N/A22 (75.9%)

Trials by Status

unknown1117%
active_not_recruiting46%
completed2335%
terminated35%
enrolling_by_invitation12%
recruiting1625%
withdrawn46%
not_yet_recruiting35%

Recent Activity

20 active trials
Showing 5 of 65
recruiting

Hepatic Lipid Metabolism-Alcohol Use Disorder

NCT07191561
not_yet_recruiting

Liver Biopsy Following Gene Therapy For Hemophilia

NCT05932914
enrolling_by_invitationnot_applicable

Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation

NCT07735650
not_yet_recruitingphase_2

Bepirovirsen Liver Biopsy Study

NCT07696520
active_not_recruiting

The HOPE Study: Characterizing Patients With Hepatitis B and C

NCT02995252
View all 65 trials

Clinical Trials (65)

Showing 20 of 65 trialsScroll for more
NCT07191561

Hepatic Lipid Metabolism-Alcohol Use Disorder

Recruiting
NCT05932914

Liver Biopsy Following Gene Therapy For Hemophilia

Not Yet Recruiting
NCT07735650Not Applicable

Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation

Enrolling By Invitation
NCT07696520Phase 2

Bepirovirsen Liver Biopsy Study

Not Yet Recruiting
NCT02995252

The HOPE Study: Characterizing Patients With Hepatitis B and C

Active Not Recruiting
NCT03302481Not Applicable

Mitochondrial Metabolism and Hepatic Complications of Obesity

Withdrawn
NCT03193151

Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation

Recruiting
NCT03900429Phase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Active Not Recruiting
NCT05623150

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

Recruiting
NCT06218589Not Applicable

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Active Not Recruiting
NCT06345508

Early Detection of Liver Cancer by QUS

Recruiting
NCT06779058

MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B

Recruiting
NCT04365855Not Applicable

The Olmsted NAFLD Epidemiology Study (TONES)

Recruiting
NCT06797193Not Applicable

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

Recruiting
NCT06470997

Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

Recruiting
NCT03694691Not Applicable

Developing Viability Index for Machine Perfused Livers

Recruiting
NCT06592820

Endoscopic Ultrasound Shear Wave Elastography Study

Recruiting
NCT05499949

The Franciscus Obesity NASH Study

Active Not Recruiting
NCT02206841

Establishment of NAFLD Cohort and Development of Fibrosis Markers

Recruiting
NCT04817462Not Applicable

Liver Biopsy In Haemophilia Gene Therapy

Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
65